BURLINGTON, Vt.– A more infectious COVID-19 variation has been identified in Vermont for the very first time, state health authorities said Monday. The B. 1.1.7 variant, very first found in the United Kingdom, was discovered in a test for a Chittenden County resident. Health officials revealed a “likely existence” of the variant in mid-February after wastewater sampling identified alternative mutations.
Vermont Health Commissioner Mark Levine stated the findings did not come as a surprise. “This and other variations have been circulating throughout the U.S. for some time, so we expected to find proof here,” Levine stated. “In truth, we are the last New England state where it has been detected.”Data from the Centers for Disease Control and Prevention reveal just two states– South Dakota and Oklahoma– have actually not recorded a case of the variation. Vaccine producers have actually said their vaccines ought to still offer some protection against this version, though Moderna has actually sent a variant-specific vaccine prospect for clinical research study.
“We are moving to immunize people as rapidly as possible, and I ask everyone who is qualified for each stage to get immunized,” Levine said. “But now that we understand the variant is here, it is ever more vital that everyone follow our assistance to prevent transmission.”Vermont moved to a brand-new vaccine distribution stage Monday, opening the shots to homeowners in between 55 and 64 with certain high-risk health conditions.
A more transmittable COVID-19 version has been spotted in Vermont for the first time, state health officials said Monday. Health authorities announced a “likely existence” of the variant in mid-February after wastewater tasting found variant mutations. Vaccine producers have stated their vaccines ought to still provide some security versus this version, though Moderna has sent a variant-specific vaccine candidate for medical research study.
Health officials revealed a “most likely presence” of the variant in mid-February after wastewater tasting detected alternative mutations. Vaccine makers have stated their vaccines should still provide some defense versus this variant, though Moderna has submitted a variant-specific vaccine candidate for scientific research study. Health officials revealed a “likely presence” of the variant in mid-February after wastewater sampling discovered variant anomalies.
Vaccine producers have said their vaccines ought to still offer some protection versus this version, though Moderna has actually sent a variant-specific vaccine prospect for medical research study.